Beyond ALK and EGFR: Novel Molecularly Driven Targeted Therapies in NSCLC

Date 22 March 2017
Event ESMO Preceptorship on Lung Cancer Manchester March 2017
Session Session 3 Advanced NSCLC
Topics Non-Small-Cell Lung Cancer, Metastatic
Personalised Medicine
Biomarkers
Presenter F. Cappuzzo, IT